Abstract

The aim. To review the composition of gut microbiota in the presence of metabolic syndrome. Materials and methods. Authors analysed Russian and foreign research publications of the database PubMed and Electronic Research eLibrary over the last 20 years from the position of evidence-based medicine. An analytical method has been used. Results. A literature review showed the ambivalence of composition of gut microbiota phyla in the presence of metabolic syndrome, but indicated on specific species whose number correlates with the manifestations of metabolic syndrome. Among such bacteria can be highlighted Faecalibacterium prausnitzii, which can be the obesity risk indicator and also bacteria of genus Lactobacillus and the class Betaproteobacteria which have confirmed inverse and direct links with the blood glucose level in patients with type 2 diabetes. Special attention should be given to Proteobacteria species (Escherichia coli, Citrobacter, Shigella, Staphylococcus aureus, Enterobacter), which are found in larger quantities in patients with manifestations of metabolic syndrome. Conclusion. According to recent studies the role of gut microbiota in the development of metabolic syndrome is not in doubt. Specific bacteria species can be considered as predictors of the metabolic syndrome presence. The composition of gut microbiota phyla in the presence of metabolic syndrome requires further studies.

Highlights

  • A literature review showed the ambivalence of composition of gut microbiota phyla in the presence of metabolic syndrome, but indicated on specific species whose number correlates with the manifestations of metabolic syndrome

  • Special attention should be given to Proteobacteria species (Escherichia coli, Citrobacter, Shigella, Staphylococcus aureus, Enterobacter), which are found in larger quantities in patients with manifestations of metabolic syndrome

  • Specific bacteria species can be considered as predictors of the metabolic syndrome presence

Read more

Summary

Роль кишечной микробиоты в развитии метаболического синдрома

Котрова А. Д.1, Шишкин А. Н.1, Семенова О. И.2, Слепых Л. А.1 1 ФГБОУ ВО «Санкт-Петербургский государственный университет», 199034, Россия, Санкт-Петербург, Университетская наб., д. 7–9 2 СПб ГБУЗ «Городская Александровская больница», 193312 Санкт-Петербург, Россия, пр. Солидарности, д. 4

The role of gut microbiota in the development of metabolic syndrome
Materials and methods
Results
Conclusion
Микробиота толстой кишки и ее вклад в развитие системного воспаления
Микробиота и ожирение
Микробиота и артериальная гипертензия
Микробиота и дислипидемия
Микробиота и гипергликемия

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.